
Aprea Therapeutics Investor Relations Material
Latest events

Study Update
Aprea Therapeutics

Q1 2025
14 May, 2025

Q4 2024
25 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aprea Therapeutics Inc
Access all reports
Aprea Therapeutics Inc. is a biopharmaceutical company focused on developing cancer treatments. The company specializes in small-molecule therapies that target tumor suppressor pathways to address various malignancies. Its research and development efforts aim to enhance the effectiveness of existing treatments and explore novel therapeutic approaches. The company is headquartered in Doylestown, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for Aprea Therapeutics Inc


Corporate Presentation
Aprea Therapeutics Inc


Corporate Presentation
Aprea Therapeutics Inc
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
APRE
Country
🇺🇸 United States